1 / 7

Regenerative Medicine Market Share, Leading Players and Forecast Report 2024

Technological innovations in the area of stem cell therapy and tissue engineering has led to rapid growth of the regenerative medicine market size.

psmarket
Download Presentation

Regenerative Medicine Market Share, Leading Players and Forecast Report 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Regenerative Medicine Market Size, Share, Growth Drivers and Forecast Report 2024

  2. The global regenerative medicine market sizeis expected to witness significant growth during the forecast period, due to the increase in the prevalence of chronic diseases, orthopaedic injuries, genetic disorders, growing aging population, increasing government funding along with the private funding in the research & development of regenerative medicines with the advancement in nanotechnology based drug delivery system, and moderate healthcare reforms. Currently, major breakthrough in the area is the development of tissue engineered trachea, transplantation of retinal pigment differentiated by stem cell based therapy to treat age-related macular degeneration. However, recently research labs have started to focus on regenerating solid organs such as heart, kidney, lungs and other organs to curb the problems associated with organ transplantation. Explore report at: https://www.psmarketresearch.com/market-analysis/regenerative-medicine-market “

  3. Technological innovations in the area of stem cell therapy and tissue engineering has led to rapid growth of the regenerative medicine market size. The key factors which drive the growth of the global market include increase in the demand of orthopaedic surgeries, government healthcare reforms in certain countries such as the U.S. and Canada, aging population, rise in chronic diseases, increasing prevalence of bone and joint diseases, and innovations in nanotechnology that aids in drug delivery mechanism. However, stringent regulations, ethical issues, and the risk of product failure and their recall are the key barriers for the growth of the regenerative medicine market. The cost of regenerative medicine treatment is significantly high and it is less effective in case of geriatric patients, which hinders the growth of the global market to some extent.

  4. With the rising prevalence of chronic disorders and age-related ailments, treatment procedures such as organ transplant is the only viable option available in some cases of these disease. There has been a long-term shortage of organs for transplantations which provides ample opportunities to the key players to increase their regenerative medicine market size by offering an alternative approach to organ transplant. With the improvement in regenerative medicine technology, regenerative medicines can possibly be an inexhaustible source of organs. Also, regenerative medicines offer the advantage of immunosuppressant-free transplantations of tissues or organs as required. These advantages of regenerative medicines present lucrative opportunity to the players in the global market. Request for report sample at: https://www.psmarketresearch.com/market-analysis/regenerative-medicine-market/report-sample

  5. Globally, North America is the largest market for regenerative medicine followed by Europe. The largest regenerative medicine market size of North America is attributed to the high rate of incidence of cardiac disorders, autoimmune diseases, and increasing prevalence of cancer patients among the American population. Additionally, the involvement of government organization for funding in the area of R&D of regenerative medicines, technological advancement and other policies are driving the growth of the North American market. Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=regenerative-medicine-market

  6. Key companies are acquiring other companies to strengthen their regenerative medicine market share. For instance, in August 2016, Medtronic Inc. had acquired Heart Ware International, Inc., that offers less-invasive, miniaturized, mechanical circulatory support (MCS) techniques as an advanced heart failure treatment. This acquisition was aimed at increasing the working efficiency of the company and to broaden its product portfolio. Some of the other key players operating in the global market include Acelity L.P. Inc., NuVasive Inc., Vericel Corporation, Osiris therapeutics Inc., Integra Lifesciences Corporation, Stryker Corporation, Cook Biotech Incorporated, Organogenesis Inc., and Japan Tissue Engineering Co. Ltd.

  7. THANK YOU! For queries, kindly write to: enquiry@psmarketresearch.com GET IN TOUCH www.psmarketresearch.com B-13, Sector-2, Noida, U.P.-201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 US/Canada Toll-Free: 1-888-778-7886

More Related